Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · IEX Real-Time Price · USD
137.83
-3.33 (-2.36%)
At close: Mar 27, 2024, 4:00 PM
139.00
+1.17 (0.85%)
Pre-market: Mar 28, 2024, 4:02 AM EDT

Neurocrine Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1995
Cash & Equivalents
251.1262.9340.8187.1115.5147.19259.2188.1578.9935.85
Upgrade
Short-Term Investments
780.5726.4370.5613.9558.2509.2261.22224.08305162.8
Upgrade
Cash & Cash Equivalents
1,032989.3711.3801673.7656.39520.43312.23383.98198.64
Upgrade
Cash Growth
4.28%39.08%-11.20%18.90%2.64%26.12%66.68%-18.69%93.31%32.27%
Upgrade
Receivables
439.3350185.5157.1126.657.4131.13000
Upgrade
Inventory
38.335.130.52817.310.861.02000
Upgrade
Other Current Assets
97.879.145.530.113.413.122.34-1.790.09-0.44
Upgrade
Total Current Assets
1,6071,454972.81,016831737.78554.92310.44384.07198.2
Upgrade
Property, Plant & Equipment
347.3145.6155.8127.4116.233.8710.816.273.432.51
Upgrade
Long-Term Investments
849.4401.5624.4265.3355.6216.03247.3643.4982.4937.49
Upgrade
Goodwill and Intangibles
35.537.200000000
Upgrade
Other Long-Term Assets
412.2330.9319.5325.83.25.484.54.884.794.83
Upgrade
Total Long-Term Assets
1,644915.21,100718.5475255.37262.6754.6490.7144.83
Upgrade
Total Assets
3,2512,3692,0731,7351,306993.15817.59365.09474.79243.03
Upgrade
Accounts Payable
448.8347.6225.8168.7141.386.3853.5226.182.560.25
Upgrade
Deferred Revenue
00000010.2310.2310.230
Upgrade
Current Debt
170.1169.400408.800000
Upgrade
Other Current Liabilities
35.920.72017.815.21.86-9.33-612.9215.42
Upgrade
Total Current Liabilities
654.8537.7245.8186.5565.388.2354.4330.4125.7215.66
Upgrade
Long-Term Debt
258.393.5440.4412.386.7388.5369.62000
Upgrade
Other Long-Term Liabilities
106.329.712.39.717.135.6621.4119.824.6218.67
Upgrade
Total Long-Term Liabilities
364.6123.2452.7422103.8424.15391.0319.824.6218.67
Upgrade
Total Liabilities
1,019660.9698.5608.5669.1512.39445.4550.2150.3334.33
Upgrade
Total Debt
428.4262.9440.4412.3495.5388.5369.62000
Upgrade
Debt Growth
62.95%-40.30%6.82%-16.79%27.54%5.11%----
Upgrade
Retained Earnings
-157.1-406.8-635.8-725.4-1,132.7-1,177.76-1,198.87-1,056.32-915.23-826.31
Upgrade
Comprehensive Income
7-7.9-1.71.81.4-1.93-1.85-0.32-0.98-0.28
Upgrade
Shareholders' Equity
2,2321,7081,3741,126636.9480.77372.14314.88424.45208.7
Upgrade
Net Cash / Debt
603.2726.4270.9388.7178.2267.89150.81312.23383.98198.64
Upgrade
Net Cash / Debt Growth
-16.96%168.14%-30.31%118.13%-33.48%77.64%-51.70%-18.69%93.31%32.27%
Upgrade
Net Cash Per Share
5.977.342.773.971.862.811.713.604.542.66
Upgrade
Working Capital
952.2915.8727829.7265.7649.54500.49280.03358.36182.54
Upgrade
Book Value Per Share
22.8417.8314.5212.106.955.334.223.635.022.80
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).